Korkmaz, T. Et Al. 2016. Review of the current role of targeted therapies as maintenance therapies in first and second line treatment of epithelial ovarian cancer; In the light of completed trials. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.98 , 180-188.

Korkmaz, T., Seber, S., & Basaran, G., (2016). Review of the current role of targeted therapies as maintenance therapies in first and second line treatment of epithelial ovarian cancer; In the light of completed trials. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.98, 180-188.

Korkmaz, Taner, Selcuk Seber, And Gül BAŞARAN. "Review of the current role of targeted therapies as maintenance therapies in first and second line treatment of epithelial ovarian cancer; In the light of completed trials," CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.98, 180-188, 2016

Korkmaz, Taner Et Al. "Review of the current role of targeted therapies as maintenance therapies in first and second line treatment of epithelial ovarian cancer; In the light of completed trials." CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.98, pp.180-188, 2016

Korkmaz, T. Seber, S. And Basaran, G. (2016) . "Review of the current role of targeted therapies as maintenance therapies in first and second line treatment of epithelial ovarian cancer; In the light of completed trials." CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.98, pp.180-188.

@article{article, author={Taner KORKMAZ Et Al. }, title={Review of the current role of targeted therapies as maintenance therapies in first and second line treatment of epithelial ovarian cancer; In the light of completed trials}, journal={CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY}, year=2016, pages={180-188} }